Triple-negative breast Cancer (TNBC) stands out as a highly aggressive form of breast cancer distinguished by the lack of expression of certain receptors, namely human epidermal growth factor receptor 2 (HER2), estrogen, and progesterone (1). This evidence concerns the gene ERBB2 and breast carcinoma.